Reflect Scientific, Inc.
RSCF
$0.0397
-$0.0003-0.75%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.72M | 1.73M | 1.27M | 1.08M | 1.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.72M | 1.73M | 1.27M | 1.08M | 1.37M |
| Cost of Revenue | 715.10K | 724.80K | 557.20K | 483.80K | 643.20K |
| Gross Profit | 1.01M | 1.01M | 710.70K | 596.40K | 727.00K |
| SG&A Expenses | 1.05M | 1.06M | 1.04M | 1.03M | 1.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.78M | 1.81M | 1.63M | 1.55M | 1.68M |
| Operating Income | -62.60K | -80.90K | -360.00K | -467.30K | -309.00K |
| Income Before Tax | -29.40K | -53.10K | -342.90K | -458.70K | -303.60K |
| Income Tax Expenses | 100.00 | 0.00 | 300.00 | 300.00 | 300.00 |
| Earnings from Continuing Operations | -0.03 | -0.05 | -0.34 | -0.46 | -0.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.50K | -53.10K | -343.20K | -459.00K | -303.90K |
| EBIT | -62.60K | -80.90K | -360.00K | -467.30K | -309.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 342.22M | 341.77M | 341.32M | 340.87M | 340.64M |
| Average Diluted Shares Outstanding | 342.22M | 342.22M | 341.77M | 341.32M | 341.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |